JP Morgan Chase
TARA icon

JP Morgan Chase’s Protara Therapeutics TARA Stock Holding History

JP Morgan Chase’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94K Buy
22,608
+1,118
+5% +$5.32K ﹤0.01% 6102
2026
Q1 		$104K Buy
21,490
+6,906
+47% +$40.9K ﹤0.01% 5806
2025
Q4 		$77.7K Buy
14,584
+247
+2% +$1.37K ﹤0.01% 6018
2025
Q3 		$62.4K Sell
14,337
-927
-6% -$3K ﹤0.01% 6146
2025
Q2 		$46.3K Buy
+15,264
New +$52.7K ﹤0.01% 5956
2024
Q2 		– Sell
-22
Closed -$88 – 7736
2024
Q1 		$88 Buy
22
+6
+38% +$19 ﹤0.01% 6928
2023
Q4 		$30 Buy
16
+5
+45% +$7 ﹤0.01% 7283
2023
Q3 		$18 Buy
+11
New +$25 ﹤0.01% 7197
2022
Q3 		– Sell
-352
Closed -$1K – 6846
2022
Q2 		$1K Buy
+352
New +$1.29K ﹤0.01% 6383
2022
Q1 		– Sell
-1,103
Closed -$7K – 7005
2021
Q4 		$7K Sell
1,103
-6,937
-86% -$47.8K ﹤0.01% 6385
2021
Q3 		$56K Buy
8,040
+7,863
+4,442% +$61.3K ﹤0.01% 5803
2021
Q2 		$2K Sell
177
-1,376
-89% -$15.6K ﹤0.01% 6214
2021
Q1 		$24K Sell
1,553
-160
-9% -$2.97K ﹤0.01% 5677
2020
Q4 		$41K Buy
1,713
+198
+13% +$4.27K ﹤0.01% 5202
2020
Q3 		$26K Sell
1,515
-29
-2% -$672 ﹤0.01% 5102
2020
Q2 		$45K Buy
1,544
+1,292
+513% +$40K ﹤0.01% 4858
2020
Q1 		$6K Buy
+252
New +$7.34K ﹤0.01% 5106

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

JP Morgan Chase's TARA Position: Q2 2026 in Review

JP Morgan Chase increased its Protara Therapeutics (TARA) stake by 5.2% in Q2 2026, buying an estimated $5.32K and bringing the position to 22,608 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #6102.

JP Morgan Chase first reported a position in TARA in Q1 2020 and has held it in 17 quarters since. The position peaked at $104K in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • JP Morgan Chase held 22,608 shares of Protara Therapeutics worth $94K as of Q2 2026.
  • JP Morgan Chase bought 1,118 Protara Therapeutics shares in Q2 2026, an estimated $5.32K.
  • Protara Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6102 holding.
  • JP Morgan Chase first reported a position in Protara Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • JP Morgan Chase's Protara Therapeutics position peaked at $104K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.